Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3759

Immunodiagnostics Market by Product (Reagents, Instruments, and Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Radioimmunoassay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Rapid Test, and Others) - Global Opportunity Analysis and Industry Forecasts, 2014-2022

LI 161763
Pages: 175
Nov 2016 | 1884 Views
face gplus_n
Author's : Garima Chandra
Tables: 83
Charts: 48
twit_n pr_n

Immunodiagnostics Market Overview

Immunodiagnostics market is expected to garner $17,836 Million by 2022, registering a CAGR of 7.3% during the forecast period 2016-2022. Immunodiagnostics is the branch of in vitro diagnostics that deals with the diagnosis of several diseases on the basis of antigen antibody reaction. Its a primary means for diagnosing infectious disease, chronic diseases such as cancer and cardiovascular diseases, autoimmunity diseases, and endocrinology among others. The significant advancement in the immunodiagnostics technologies have enhanced the ability to target the areas to diagnose disease progression. The growth in development has improved the diagnosis of complex diseases. The immunodiagnostics market is segmented based on product type into reagents, instruments, and software & services. The infectious diseases holds a remarkable share in the global immunodiagnostics market and is expected to maintain its lead during the study period. This is attributed by the growth in preference of automated and next generation immunodiagnostics platform due to accurate, rapid and reliable outcomes and increased adoption by the clinicians.

Market Dynamics:

The rise in incidences of infectious diseases (HIV, STI, hepatitis B, and others), cardiovascular diseases, cancer, gastrointestinal, and other chronic diseases across the world owing to the growth in aged population and changes in demographics & lifestyle are the major factors to drive the growth of the immunodiagnostics market. In addition, technological advancement in diagnosis kits, assays and analyzers and increase in awareness of the preventive health measures among the patients and medical professionals further stimulate the demand for immunodiagnostics products thus boosting the growth. However, numerous factors are expected to restrain the market development. The impact of the drivers is estimated to be higher than the restraints. Moreover, an increase in effect of the drivers and the restraints is anticipated to reveal new market opportunities for key players manufacturing immunodiagnostics products especially the kits and assays.

Clinical laboratories

Pathologists generally operate independently and have tie ups and collaborations with some hospital or clinics. The demand for the immunodiagnostic analysis has led to the increased profits of these laboratories. Laboratory test includes the examinations for infectious and viral diseases, such as HIV, hepatitis, dengue, and chikungunya. Different laboratory tests are also designed to execute routine blood tests for anemia, autoimmune diseases, and others. Various devices are available to test, classify, and diagnose diseases such as the immunoglobulin test, rheumatoid factor tests, and Human Leukocyte Typing (HLA typing) tests.

Hospitals

The immunodiagnostics tests can be performed in various hospital departments, such as serological labs, pathological labs, clinical microbiology departments, histopathology and hematology sections, clinical biochemistry laboratories, and hospital wards. However, complex as well as the simple tests can be performed in hospitals. Some of the immunodiagnostics instruments give quick results and in case of complex tests, the sample is sent to the concerned laboratories. Various tests in hospitals include, Enzyme-Linked Immunosorbent Assay, western blot, infectious tests, and other immunological assays.

Academic and Research centers

Trainings provided in academic and research centers and medical colleges in the form of internships and training sessions. These training and education services comprise a large market for immunodiagnostics. The training in these centers is carried out with the help of different instruments such as flow cytometer and HPLC. The increased use of these instruments has surged the demand for these equipment worldwide. Proper training for usage of immunodiagnostics products such as, kits, assays, and analyzers, their maintenance, and disposal is given through these educational services. Some of the universities also provide online trainings for the use of immunodiagnostics.

Pharmaceutical and Biotechnology Industry

Biotechnology deals with the employment of natural based material, plant material, organisms, and natural processes to design and produce products that are overall beneficial and improve the quality of human life. Different substances for instance, biomolecules such as proteins can act as immunodiagnostic agents to execute significant immunodiagnostic processes. After clinical laboratories and hospitals, the pharmaceutical and biotechnology industries are the traditional strongholds of the immunodiagnostic market. Immunodiagnostic kits are widely used by druggists to monitor drug delivery and the effect of the drugs administered in the system.

Others

Immunodiagnostics has various other end users such as contract research organizations (CROs), blood banks, local public health laboratories, community clinics, home health agencies, nursing homes, and ambulatory surgical services and centers.

Abbott Laboratories, Immunodiagnostic Systems Holdings Plc (IDS), DiaSorin S.p.A., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Siemens AG, Sysmex Corporation, Danaher Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., and Arkray, Inc. are the key players that operate in the global immunodiagnostics market.

Other players in the value chain include Arkray, Inc., Alere, Inc., Merck Millipore, Becton, Dickinson and Company, Biomerieux SA, Medicaroid Corporation, Qiagen NV, Affimetrix, ImmunoDX, Meridian Bioscience and others

Immunodiagnostics Market Key Benefits

  • The study provides an in-depth analysis of the global immunodiagnostics market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.
  • Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.
  • Porters Five Forces model will interpret the bargaining power of suppliers and buyers, threat of new entrants and substitutes, and competition amongst the key players.
  • Extensive analysis is conducted by following key product positioning and monitoring the top competitors within the market framework.

Immunodiagnostics Market Key Segments

By Product

  • Reagents
  • Instruments
  • Software & Services

By Technology

  • Enzyme-Linked Immunosorbent Assay
  • Chemiluminescence Immunoassay
  • Fluorescent Immunoassay
  • Radioimmunoassay
  • Rapid Test
  • Others

By Application

  • Infectious diseases
  • Oncology & endocrinology
  • Hepatitis & retrovirus
  • Bone & mineral
  • Autoimmunity,
  • Cardiac biomarker
  • Others

By End User

  • Clinical laboratories
  • Hospitals
  • Academic & Research Centers
  • Pharmaceutical & Biotechnology Industry
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • U.K.
    • France
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa
 

Chapter: 1. INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2. EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY:
2.2. CXO PERSPECTIVE

Chapter: 3. MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTER’S FIVE FORCES ANALYSIS

3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of new entrants
3.3.4. Threat of substitute
3.3.5. Competitive rivalry

3.4. VALUE CHAIN ANALYSIS
3.5. GOVERNMENT REGULATIONS
3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Rising incidence of chronic and infectious diseases and a growing geriatric population
3.6.1.2. Technological advancements
3.6.1.3. Increasing need for accurate, precise and rapid diagnostic tests
3.6.1.4. Growth in demand for next generation immunodiagnostics platform
3.6.1.5. Demand for personalized medicine

3.6.2. Restraints

3.6.2.1. High cost of immunodiagnostic products
3.6.2.2. Stringent government regulations
3.6.2.3. Reluctance in adoption of advanced technologies in emerging economies

3.6.3. Opportunities

3.6.3.1. Presence of large unmet diagnostic needs in emerging economies
3.6.3.2. Conjunction of personalized and point of care technologies

Chapter: 4. IMMUNODIAGNOSTICS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. REAGENTS & CONSUMABLES

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. INSTRUMENT

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. SOFTWARE & SERVICES

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5. IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)

5.2.1. Market size and forecast

5.3. CHEMILUMINESCENCE IMMUNOASSAY (CLIA)

5.3.1. Market size and forecasts

5.4. RADIOIMMUNOASSAY (RIA)

5.4.1. Market size and forecast

5.5. FLUORESCENCE IMMUNOASSAY (FIA)

5.5.1. Market size and forecast

5.6. RAPID TESTS

5.6.1. Market size and forecast

5.7. OTHERS

5.7.1. Market size and forecast

Chapter: 6. IMMUNODIAGNOSTICS MARKET, BY APPLICATION

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. INFECTIOUS DISEASES

6.2.1. Market size and forecast

6.3. ONCOLOGY AND ENDOCRINOLOGY

6.3.1. Market size and forecast

6.4. BONE AND MINERAL DISEASES

6.4.1. Market size and forecast

6.5. AUTOIMMUNITY DISORDERS

6.5.1. Market size and forecast

6.6. CARDIAC BIOMARKERS

6.6.1. Market size and forecast

6.7. DRUG MONITORING

6.7.1. Market size and forecast

6.8. OTHER APPLICATIONS

6.8.1. Market size and forecast

Chapter: 7. IMMUNODIAGNOSTICS MARKET, BY END USERS

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. HOSPITALS

7.2.1. Market size and forecast

7.3. CLINICAL LABORATORIES

7.3.1. Market size and forecast

7.4. ACADEMIC AND RESEARCH CENTERS

7.4.1. Market size and forecast

7.5. PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY

7.5.1. Market size and forecast

7.6. OTHERS

7.6.1. Market size and forecast

Chapter: 8. IMMUNODIAGNOSTICS MARKET, BY GEOGRAPHY

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast

8.2.3.1. U.S.Market size and forecast
8.2.3.2. canada Market size and forecast
8.2.3.3. Mexico Market size and forecast

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast

8.3.3.1. Germany Market size and forecast
8.3.3.2. France Market size and forecast
8.3.3.3. UK Market size and forecast
8.3.3.4. Rest of Europe Market size and forecast

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast

8.4.3.1. India Market size and forecast
8.4.3.2. China Market size and forecast
8.4.3.3. Japan Market size and forecast
8.4.3.4. Australia Market size and forecast
8.4.3.5. Other Asia-Pacific Market size and forecast

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast

8.5.3.1. Latin America Market size and forecast
8.5.3.2. Middle East Market size and forecast
8.5.3.3. Africa Market size and forecast

Chapter: 9. COMPANY PROFILES

9.1. ABBOTT LABORATORIES

9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Operating Business Segments
9.1.4. Business Performance
9.1.5. Key Strategic Moves & Developments

9.2. ARKRAY, INC.

9.2.1. Company Overview
9.2.2. Operating Business Segments
9.2.3. Key Strategies and Development

9.3. IMMUNODIAGNOSTIC SYSTEMS HOLDINGS PLC

9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Operating business segments overview
9.3.4. Business Performance
9.3.5. Strategic Moves and Developments

9.4. DIASORIN S.P.A.

9.4.1. Company overview
9.4.2. Operating business segments
9.4.3. Business performance
9.4.4. Strategic moves and developments

9.5. JOHNSON & JOHNSON SERVICES, INC.

9.5.1. Company overview
9.5.2. Operating business segments
9.5.3. Business performance
9.5.4. Key strategies and development

9.6. F. HOFFMANN-LA ROCHE LTD.

9.6.1. Company overview
9.6.2. Operating Business Segments
9.6.3. Business performance
9.6.4. Key strategies and developments

9.7. SYSMEX CORPORATION

9.7.1. Company overview
9.7.2. Operating Business Segments
9.7.3. Business performance
9.7.4. Key strategies and developments

9.8. DANAHER CORPORATION (BECKMAN COULTER)

9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Operating Business Segments
9.8.4. Business Performance
9.8.5. Key Strategic Moves and Developments

9.9. THERMO FISHER SCIENTIFIC, INC.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments

9.10. BIO-RAD LABORATORIES, INC.

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments

9.11. SIEMENS AG

9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Operating Business Segments
9.11.4. Financial Performance
9.11.5. Key Strategic Moves and Developments

 List of Tables

TABLE 1. WORLD IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 2. WORLD IMMUNODIAGNOSTICS REAGENTS AND CONSUMABLES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 3. WORLD IMMUNODIAGNOSTICS INSTRUMENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 4. WORLD IMMUNODIAGNOTICS SOFTWARE & SERVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 5. WORLD IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 6. WORLD ELISA MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 7. WORLD CLIA MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 8. WORLD RIA MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 9. WORLD FIA MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 10. WORLD RAPID TEST MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 11. WORLD OTHER TECHNOLOGIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 12. WORLD IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 13. WORLD IMMUNODIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 14. WORLD IMMUNODIAGNOSTICS MARKET FOR ONCOLOGY AND ENDOCRINOLOGY, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 15. WORLD IMMUNODIAGNOSTICS MARKET FOR BONE AND MINERAL DISEASES, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 16. WORLD IMMUNODIAGNOSTICS MARKET FOR AUTOIMMUNITY DISEASES, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 17. WORLD IMMUNODIAGNOSTICS MARKET FOR CARDIAC BIOMARKERS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 18. WORLD IMMUNODIAGNOSTICS MARKET FOR DRUG MONITORING, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 19. WORLD IMMUNODIAGNOSTICS MARKET FOR OTHER APPLICTIONS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20. WORLD UMMUNODIAGNOSTICS MARKET, BY END USER, 2014-2022, ($MILLION)
TABLE 21. WORLD IMMUNODIAGNOSTICS MARKET FOR HOSPITALS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 22. WORLD IMMUNODIAGNOSTICS MARKET FOR CLINICAL LABORATORIES, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 23. WORLD IMMUNODIAGNOSTICS MARKET FOR ACADEMIC AND RESEARCH CENTERS, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 24. WORLD IMMUNODIAGNOSTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRY, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 25. WORLD IMMUNODIAGNOSTICS MARKET FOR OTHER END USER, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 26. WORLD IMMUNODIAGNOSTICS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 27. NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 28. NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 29. NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 30. NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 31. NORTH AMERICA IMMUNODIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 32. U.S.: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 33. CANADA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 34. MEXICO: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 35. EUROPE IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 36. EUROPE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 37. EUROPE IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 38. EUROPE IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 39. EUROPE IMMUNODIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 40. GERMANY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 41. FRANCE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 42. UK: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 43. REST OF EUROPE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 44. ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 45. ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 46. ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 47. ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 48. ASIA-PACIFIC IMMUNODIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 49. INDIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 50. CHINA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 51. JAPAN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 52. AUSTRALIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 53. OTHER ASIA-PACIFIC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 54. LAMEA IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 55. LAMEA IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 56. LAMEA IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY, 2014-2022 ($MILLION)
TABLE 57. LAMEA IMMUNODIAGNOSTICS MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 58. LAMEA IMMUNODIAGNOSTICS MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 59. LATIN AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 60. MIDDLE EAST: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 61. AFRICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)
TABLE 62. ABBOTT: COMPANY SNAPSHOT
TABLE 63. ABBOTT: OPERATING SEGMENTS
TABLE 64. ARKRAY, INC. COMPANY SNAPSHOT
TABLE 65. ARKRAY, INC.: OPERATING SEGMENTS
TABLE 66. IDS—COMPANY SNAPSHOT
TABLE 67. TABLE 2 IDS: OPERATING SEGMENTS
TABLE 68. DIASORIN—COMPANY SNAPSHOT
TABLE 69. DIASORIN: OPERATING SEGMENTS
TABLE 70. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 71. JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 72. ROCHE: COMPANY SNAPSHOT
TABLE 73. ROCHE: OPERATING SEGMENTS
TABLE 74. SYSMEX CORPORATION: COMPANY SNAPSHOT
TABLE 75. SYSMEX CORPORATION: OPERATING SEGMENTS
TABLE 76. DANAHER: COMPANY SNAPSHOT
TABLE 77. DANAHER: OPERATING SEGMENTS
TABLE 78. THERMO FISHER: COMPANY SNAPSHOT
TABLE 79. THERMO FISHER: OPERATING SEGMENTS
TABLE 80. BIO-RAD: COMPANY SNAPSHOT
TABLE 81. BIO-RAD: OPERATING SEGMENTS
TABLE 82. SIEMENS: COMPANY SNAPSHOT
TABLE 83. SIEMENS: OPERATING SEGMENTS

 List of Figures

FIGURE 1. TOP INVESTMENT POCKETS IN IMMUNODIAGOSTICS MARKET
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 5. PORTER’S FIVE FORCES ANALYSIS
FIGURE 6. VALUE CHAIN ANALYSIS FOR IMMUNODIAGNOSTICS MARKET
FIGURE 7. RESTRAINTS AND DRIVERS: WORLD IMMUNODIAGNOSTICS MARKET
FIGURE 8. GLOBAL INCIDENCE OF DISEASES
FIGURE 9. IMMUNODIAGNOSTICS TECHNOLOGY
FIGURE 10. GENERAL CLASSIFICATION OF INFECTIOUS DISEASES
FIGURE 11. ESTIMATED NUMBER OF CANCER DEATHS BY SEX, U.S., 2016
FIGURE 12. ESTIMATED NUMBER OF HIV-RELATED DEATHS, SOUTH AFRICA, 2016
FIGURE 13. ABBOTT: NET SALES, 2013-2015 ($MILLION)
FIGURE 14. ABBOTT: REVENUE BY BUSINESS SEGMENT, 2015 (%)
FIGURE 15. ABBOTT: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 16. ABBOTT: STRATEGY SHARE, 2014-2016 (%)
FIGURE 17. ARKRAY, INC.: STRATEGY SHARE, 2014-2016 (%)
FIGURE 18. IDS: REVENUE, 2013-2016 ($MILLION)
FIGURE 19. IDS: REVENUE, BY BUSINESS SEGMENT, 2016 (%)
FIGURE 20. IDS: REVENUE, BY GEOGRAPHY, 2016 (%)
FIGURE 21. DIASORIN: REVENUE, 2013-2015 ($MILLION)
FIGURE 22. DIASORIN: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIGURE 23. DIASORIN: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 24. DIASORIN: STRATEGY SHARE, 2014-2016 (%)
FIGURE 25. KEY FINANCIALS OF JOHNSON & JOHNSON, 2013-2015 ($MILLION)
FIGURE 26. JOHNSON & JOHNSON: REVENUE BY SEGMENT, 2015 (%)
FIGURE 27. JOHNSON & JOHNSON: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 28. JOHNSON & JOHNSON: STRATEGY SHARE, 2014-2016 (%)
FIGURE 29. ROCHE: NET SALES, 2013-2015 ($MILLION)
FIGURE 30. ROCHE: REVENUE BY BUSINESS SEGMENT, 2015 (%)
FIGURE 31. ROCHE: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 32. KEY FINANCIALS OF SYSMEX CORPORATION REVENUE, 2013-2015 ($MILLION)
FIGURE 33. SYSMEX CORPORATION, REVENUE BY BUSINESS SEGMENT (%), 2015
FIGURE 34. SYSMEX CORPORATION, REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 35. SYSMEX CORPORATION: STRATEGY SHARE, 2014-2016 (%)
FIGURE 36. DANAHER: NET SALES, 2013-2015 ($MILLION)
FIGURE 37. DANAHER: REVENUE BY BUSINESS SEGMENT, 2015 (%)
FIGURE 38. DANAHER: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 39. THERMO FISHER: REVENUE BUSINESS SEGMENT, 2015 (%)
FIGURE 40. THERMO FISHER: REVENUE BY GEOGRAPHY, 2015 (%)
FIGURE 41. THERMO FISHER: REVENUE, 2013-2015 ($MILLION)
FIGURE 42. BIO-RAD: REVENUE, 2013-2015 ($MILLION)
FIGURE 43. BIO-RAD: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
FIGURE 44. BIO-RAD: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 45. BIO-RAD: STRATEGY SHARE, 2014-2016 (%)
FIGURE 46. SIEMENS: NET SALES, 2013-2015 ($MILLION)
FIGURE 47. SIEMENS: REVENUE BY SEGMENT, 2015 (%)
FIGURE 48. SIEMENS: REVENUE BY GEOGRAPHY, 2015 (%)

 
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 

Get More Information About This Report

For any queries about purchasing this report, Please fill the form below:

Please input the above text in the input box or click refresh

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts